Holen Sie sich die Stockscreener-App
12.20
3.66%
-0.495
Schlusskurs vom Vortag:
$12.69
Offen:
$12.4
24-Stunden-Volumen:
2.71M
Relative Volume:
0.43
Marktkapitalisierung:
$2.18B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-2.1135
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
-14.69%
1M Leistung:
+28.68%
6M Leistung:
+65.65%
1J Leistung:
-21.84%
1-Tages-Spanne:
$12.11
$12.69
1-Wochen-Bereich:
$12.02
$14.61
52-Wochen-Spanne:
$6.76
$15.95
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
12.20 | 2.18B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
226.94 | 37.14B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
73.84 | 14.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.73 | 12.87B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
72.58 | 12.08B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
110.61 | 9.68B | 1.15B | 96.70M | -161.99M | 1.09 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Why Teladoc Health, Inc. (TDOC) Crashed on Thursday - Insider Monkey
Telemedicine Market Projected to Reach USD 317.77 Billion by 2030 - openPR
TDOC INVESTIGATION: Teladoc Health, Inc. Investigated For - GlobeNewswire
TDOC INVESTIGATION: Teladoc Health, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm - TradingView
TDOC INVESTIGATION: Teladoc Health, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm - GlobeNewswire Inc.
Telepsychiatry Market Set for Explosive Growth: USD 7.34B to USD 41.59B by 2032 - EIN News
Teladoc Health: Needs A Growth Catalyst (NYSE:TDOC) - Seeking Alpha
Why Teladoc Health (TDOC) Crashed on Tuesday? - MSN
Sector Update: Health Care Stocks Advance Late Afternoon - TradingView
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Teladoc Health, Inc. (TDOC): the Best Performing Healthcare Stock So Far in 2025 - Insider Monkey
Teladoc stock fluctuates amid short-seller claim - Investing.com India
Blue Orca Capital Says We Are Short Teladoc Health- X Post -February 19, 2025 at 12:08 pm EST - Marketscreener.com
Teladoc Health: Amazon To The Rescue, Potentially (NYSE:TDOC) - Seeking Alpha
Best Telemedicine Services for 2025 - CNET
Extensive Growth Opportunities to be Witnessed by Virtual - openPR
New Horizons in Digital Telehealth Behavior Transformation - openPR
Teladoc's SWOT analysis: virtual care leader faces growth hurdles - Investing.com
Teladoc Partners With Amazon to Expand Chronic Care Program Reach - MSN
Entropy Technologies LP Sells 93,877 Shares of Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Is Teladoc Stock a Buy? - MSN
Teladoc Health To Buy Catapult Health In $65 Million Deal - Pulse 2.0
Donna Cusano - Telehealth and Telecare Aware
Page 17 | TELADOC HEALTH INC.DL-001 Trade Ideas — DUS:4LL - TradingView
Teladoc Health (NYSE:TDOC) Price Target Raised to $13.50 at Bank of America - MarketBeat
(TDOC) Proactive Strategies - Stock Traders Daily
Teladoc Health (TDOC) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Why Teladoc Health Stock Crashed Again in 2024 - AOL
Top 10 Health Information Services Stocks Outpacing The Market In 2025 - Insider Monkey
Teladoc Health (NYSE:TDOC) Stock Price Up 9%Time to Buy? - MarketBeat
Teladoc Health, Inc. (TDOC): Among the Health Information Services Stocks Outpacing the Market in 2025 - Insider Monkey
Virtual-First Care Market Growing Trends and Demands Analysis - openPR
BofA raises Teladoc stock price target to $13.50, keeps neutral rating - MSN
Online Doctor Consultation Market Insights and Growth - openPR
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Buys Shares of 29,882 Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Teladoc Health (NYSE:TDOC) Stock Price Down 5%Here's What Happened - MarketBeat
Why Teladoc Health (TDOC) Soared Last Week? - MSN
Interesting TDOC Put Options For April 4th - Nasdaq
Teladoc Health (NYSE:TDOC) Shares Gap UpTime to Buy? - MarketBeat
Telehealth Market Size | Comprehensive Analysis and Forecast (2025–2035) - PharmiWeb.com
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.03%
2.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):